# Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction

> **NCT06725004** · PHASE3 · COMPLETED · sponsor: **Shakeela Ishrat** · enrollment: 60 (actual)

## Conditions studied

- Ovulation Induction
- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Human Chorionic Gonadotropin

## Key facts

- **NCT ID:** NCT06725004
- **Lead sponsor:** Shakeela Ishrat
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06725004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06725004, "Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06725004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*